Foundation / Corporation
Worldwide Cancer Research
04/27/18 5:00 PM British Local Time
Grants to USA, Canada, and International researchers at nonprofit research institutions to conduct research that may, in the future, decrease the prevalence of cancer or improve cancer survival. Funds may be used to support basic or translational research into the diagnosis, causes, mechanisms, treatment, or prevention of cancer.
The research described in the application should be a discrete, hypothesis-driven project, achievable within the duration of the support requested. Do not describe a large program of work - for example the work of your entire laboratory - and then request a contribution towards it - for example funding one member of the laboratory or part of the consumable costs.
Worldwide Cancer Research grants are awarded for novel research proposals that are entirely the original work of the applicants. Applications on cancer symptoms or treatment side effects are accepted only if there is a very clear link to improving cancer survival. Studies investigating the biology of a side effect or symptom alone are unlikely to be accepted.
Basic studies into fundamental cellular processes, mechanisms and molecules are within remit if it is clear that the aim of the research is to improve the understanding of cancer biology. If a project is to study the normal functioning of cellular processes, mechanisms or molecules - or to study very basic models such as yeast - evidence supporting the relevance to cancer biology must be laid out.
Applications in which human samples or data are used as an essential part of a basic/translational research project will be accepted if the following conditions are satisfied.
- Clinical costs cannot be charged to a Worldwide Cancer Research grant. This includes the costs of patient or volunteer recruitment. Applications will not be accepted that contain budget items such as patient expenses, the salaries of purely clinical staff such as research nurses, or honorariums or consultancy fees for clinical collaborators. It is also not acceptable to include costs for the clinical investigation, diagnosis or follow-up of patients involved in the research study.
- Projects that rely upon a large number of human samples or extensive clinical data must have this resource available through existing biobanks, databases or cohorts. Projects will not be accepted that would involve a considerable effort to recruit patients or volunteers for samples or data; Worldwide Cancer Research-funded projects must focus on conducting hypothesis-led research and not on infrastructure development. This applies equally to all types of research, including epidemiological studies.
Applications are assessed according to the following criteria:
- Experimental design
Grants cover the direct costs of the project including research consumables and reagents, the salaries of research staff working directly on the project, travel to conferences or to visit collaborators, and any essential services or small pieces of specialist or unusual equipment.
GrantWatch ID#: 159227
The maximum budget allowed is £250,000, but it should be noted that most of the three-year grants awarded have a budget below £200,000.
Grants are awarded for 1-3 year research projects. Successful applications submitted to the April 2018 grant round will be offered a grant that would usually start on 1st January 2019.
Project grants are awarded to a single researcher known as the Principal Investigator (PI) or Grantholder. The PI must be employed at a recognized, nonprofit research institution anywhere in the world.
The PI must have a contract of employment that will last for at least the duration of the grant requested, or be able to show evidence that their current contract would be extended if the grant were awarded. The PI will usually be a PhD-qualified tenured or tenure-track research group leader. Post-doctoral researchers with more than three years postdoctoral research experience at the time of application are also eligible to apply for a grant.
Applicants in the April 2017 grant round, whose applications failed to pass the preliminary triage review stage, will be unable to apply in the April 2018 grant round.
PIs working in groups or at institutes that receive long-term or core research funding may apply for a grant, but only for a research project that is clearly distinct from that supported by the other funding.
The Foundation does not accept applications for clinical or psychosocial research and other types of applied cancer research. This includes healthcare delivery or patient care research, health economics, public health or policy research, quality of life or behavioral studies, and clinical trials.
The Foundation will not fund animal research projects in countries or institutions that do not in our view have sufficient controls on laboratory animal welfare. For further details see the animal research policy at the end of the attached handbook.
Only one application from the same research group will be accepted in a grant round.
Commercial, for-profit organizations e.g. biotechnology and pharmaceutical companies cannot apply for a grant. Neither is it permitted for a research institution to transfer Worldwide Cancer Research grant funds to a commercial organisation except for payment for specific services, items and reagents used in the project. This includes transferring money to spin-out companies from the laboratory or institute.
You cannot apply to Worldwide Cancer Research for a project grant (either as a PI or co-applicant) if you are currently applying for, or have received, funding from the tobacco industry or bodies substantially funded by the tobacco industry, within the last 10 years.
March 16, 2018 - the 2018 grant cycle opens online
March 29, 2018 - the submission window opens online
April 27, 2018 - submission deadline at 5 PM UK time
(Applications that do not meet this deadline cannot be held over for submission in the following round.)
January 1, 2019 - start of grant
Worldwide Cancer Research will only accept the first 500 applications submitted in the grant round.
If your institution does not appear in the drop-down list as part of the registration process, please contact Worldwide Cancer Research providing details of your institution and proof of the non-profit status of the organization so that it can be added to the database.
Along with the main applicant, all other application participants (including Head of Department, Authorizing Officer and Co-Applicants) must also register on the Worldwide Cancer Research online application system.
The approval of the submission by the Head of Department and Authorizing Officer is the final step in the application process. After the PI clicks the Submit button, the Head of Department has to approve the submission and then the Authorizing Officer has to approve it, in that order. It is only after they have both done this that the application is actually submitted. This must happen before the application deadline. the funding source will not extend the deadline to allow this approval to be made.
Successful applicants will be notified by email as soon as possible after the grant allocation meeting. Unsuccessful applicants will usually be notified within one month of the grant allocation meeting.
It takes approximately 9-12 months from the submission of a grant application until the start of funding for successful applications.
For more information:
Before starting your grant application, please review the funding source's website listed below for updates/changes/addendums/conferences/LOIs.
Worldwide Cancer Research
Madras House, St Andrews
Fife, Scotland, KY16 9EH
Phone: 0300 777 7910
Your main contacts at Worldwide Cancer Research when submitting a grant application are:
- Dr Lorraine Black, Grant Round Manager – for most queries, including the eligibility of applicants and specific budget items.
- Miss Yvonne Elder, Grant Round Administrator – for administrative queries, for example problems registering on the online system.
- Miss Helen Ironside, Grant Round Administrator – for administrative queries, for example problems registering on the online system.
- Dr Lynn Turner, Director of Research – for guidance about funding remit or policies.
- Mrs Debbie Peebles, Grants & Information Manager – for questions relating to grant terms and conditions and award procedures.
USA: Alabama; Alaska; Arizona; Arkansas; California; Colorado; Connecticut; Delaware; Florida; Georgia; Hawaii; Idaho; Illinois; Indiana; Iowa; Kansas; Kentucky; Louisiana; Maine; Maryland; Massachusetts; Michigan; Minnesota; Mississippi; Missouri; Montana; Nebraska; Nevada; New Hampshire; New Jersey; New Mexico; New York City; New York; North Carolina; North Dakota; Ohio; Oklahoma; Oregon; Pennsylvania; Rhode Island; South Carolina; South Dakota; Tennessee; Texas; Utah; Vermont; Virginia; Washington, DC; Washington; West Virginia; Wisconsin; Wyoming
USA Territories: American Samoa (USA) Guam (USA) Puerto Rico (USA) Virgin Islands (USA) Northern Mariana Islands (USA)
USA Compact Free Associations: The Federated States of Micronesia (USA) Marshall Islands (USA) Republic of Palau (USA)
Canada: Alberta British Columbia Manitoba New Brunswick Newfoundland and Labrador Northwest Territories Nova Scotia Nunavut Ontario Prince Edward Island Quebec Saskatchewan Yukon
International country outside of the USA, Israel and Canada.